Targeting the IL-5 pathway in eosinophilic asthma: A comparison of anti-IL-5 versus anti-IL-5 receptor agents (vol 79, pg 2943, 2024)

被引：0
|
作者：
Jackson, D. J.
Wechsler, M. E.
Brusselle, G.
Buhl, R.
机构：
来源：
ALLERGY | 2025年
关键词：
D O I：
10.1111/all.16541
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting the IL-5 pathway in eosinophilic asthma: A comparison of anti-IL-5 versus anti-IL-5 receptor agents
    Jackson, David J.
    Wechsler, Michael E.
    Brusselle, Guy
    Buhl, Roland
    ALLERGY, 2024, 79 (11) : 2943 - 2952
  • [2] Anti-IL-5 therapies for asthma
    Farne, Hugo A.
    Wilson, Amanda
    Milan, Stephen J.
    Banchoff, Emma
    Yang, Freda
    Powell, Colin V. E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (07):
  • [3] The demise of Anti-IL-5 for asthma, or not
    O'Byrne, Paul M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (11) : 1059 - 1060
  • [4] German Asthma Net: Characterization of responders to anti-IL-5 and anti-IL-5(R) therapy
    Bal, C.
    Milger, K.
    Skowasch, D.
    Schulz, C.
    Jandl, M.
    Schmidt, O.
    Ehmann, R.
    Stoshikj, S.
    Zehetmayer, S.
    Taube, C.
    Hamelmann, E.
    Buhl, R.
    Korn, S.
    Idzko, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 572 - 573
  • [5] The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis
    Nagase, Hiroyuki
    Ueki, Shigeharu
    Fujieda, Shigeharu
    ALLERGOLOGY INTERNATIONAL, 2020, 69 (02) : 178 - 186
  • [6] German Asthma Net: Characterisation of responders to anti-IL-5 and anti-IL-5(R) therapy
    Bal, Christina
    Stoshikj, Slagjana
    Renner, Andreas
    Milger, Katrin
    Skowasch, Dirk
    Schulz, Christian
    Jandl, Margret
    Schmidt, Olaf
    Ehmann, Rainer
    Zehetmayer, Sonja
    Taube, Christian
    Hamelmann, Eckard
    Buhl, Roland
    Korn, Stephanie
    Idzko, Marco
    PULMONOLOGY, 2025, 31 (01):
  • [7] Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor α levels in patients with eosinophilic esophagitis
    Conus, Sebastien
    Straumann, Alex
    Simon, Hans-Uwe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (01) : 269 - 269
  • [8] Anti-IL-5 Biologicals Targeting Severe Late Onset Eosinophilic Asthma
    Ozyigit, Leyla Pur
    Ozturk, Ayse Bilge
    Bavhek, Sevim
    TURKISH THORACIC JOURNAL, 2020, 21 (01): : 61 - 68
  • [9] Anti-IL-4R versus anti-IL-5/5R after anti-IL-5/5R failure in asthma: An emulated target trial
    Valery, Solene
    Simon-Tillaux, Noemie
    Devouassoux, Gilles
    Bonniaud, Philippe
    Beurnier, Antoine
    Boudjemaa, Amel
    Chenivesse, Cecile
    Bourdin, Arnaud
    Gauquelin, Lisa
    Guillo, Sylvie
    Taille, Camille
    Estellat, Candice
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 154 (04) : 922 - 932
  • [10] Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan (vol 84, pg 661, 2024)
    Lombardi, Carlo
    Comberiati, Pasquale
    Ridolo, Erminia
    Cottini, Marcello
    Yacoub, Mona Rita
    Casagrande, Silvia
    Ricco, Matteo
    Bottazzoli, Marco
    Berti, Alvise
    DRUGS, 2025, 85 (04) : 599 - 599
12345